Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member
tabling member	label

Search

1505297

registered interest
date	06/09/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Centres: Essex
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans he has to expand patient capacity at Riverside Medical Centre at Hullbridge, Essex; and if he will make a statement.
tabling member constituency	Rayleigh and Wickford
tabling member printed	Mr Mark Francois
uin	48261
answer	answer is ministerial correction date of answer 21/09/2022 answer text <p>There are no current plans to do so. Mid and South Essex Integrated Care Board is responsible for planning and commissioning local healthcare services, including primary medical care.</p> answering member constituency Colchester answering member printed Will Quince question first answered 21/09/2022 13:03:54 answering member 4423 label Biography information for Will Quince
tabling member	1444 label Biography information for Mr Mark Francois

1505343

registered interest
date	06/09/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cervical Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent steps his Department has taken to encourage more women to attend cervical screening appointments; and what recent steps his Department has taken to make cervical screening more accessible.
tabling member constituency	Ynys Môn
tabling member printed	Virginia Crosbie
uin	48511
answer	answer is ministerial correction date of answer 21/09/2022 answer text <p>The national ‘Help us help you’ Cervical Screening Saves Lives campaign ran in February and March 2022 to urge individuals not to ignore a cervical screening invitation and to contact their general practitioner (GP) where an invitation has been missed. In some Primary Care Networks, appointments can be made in any primary care setting in addition to the patient’s GP practice for evenings and weekends and via integrated sexual health clinics.</p><p>To support improved uptake, the effectiveness of human papillomavirus self-sampling is being evaluated. This initiative could address some barriers which prevent people from attending for screening, such as physical disability or trauma.</p> answering member constituency Colchester answering member printed Will Quince question first answered 21/09/2022 11:36:44 answering member 4423 label Biography information for Will Quince
tabling member	4859 label Biography information for Virginia Crosbie

1505532

registered interest
date	06/09/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Heart Diseases: Diagnosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what services breathlessness clinics will provide to support the early detection of heart valve disease; and whether those clinics will refer patients for auscultation using a stethoscope in primary care or community diagnostic centres.
tabling member constituency	Central Ayrshire
tabling member printed	Dr Philippa Whitford
uin	48381
answer	answer is ministerial correction date of answer 21/09/2022 answer text <p>NHS England has assessed that the use of clinical auscultation using a stethoscope is not a sensitive way of identifying the presence and clinical significance of heart valve disease or the detection of heart murmurs.</p><p>To support the early detection and diagnosis of heart valve disease NHS England has committed to launch at least 100 community diagnostic centres (CDCs) by 2024/25. These CDCs will provide services to detect heart murmurs, which are characteristic of heart valve and cardiovascular disease, through physiological measurement tests such as echocardiography and electrocardiograms, pathology tests, computerised tomography and magnetic resonance imaging scans.</p><p>In addition, the National Health Service is investing in cardiac networks to support whole pathway improvements. These networks have been developed to take an evidenced based, clinically led, whole pathway approach to improvement from prevention, diagnosis, treatment and end-of-life care.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 48382 question first answered 21/09/2022 11:18:08 answering member 4423 label Biography information for Will Quince
tabling member	4385 label Biography information for Dr Philippa Whitford

1505533

registered interest
date	06/09/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Heart Diseases: Diagnosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department plans to take to support increases in auscultation using a stethoscope in primary and community care settings to detect heart murmurs characteristic of heart valve disease.
tabling member constituency	Central Ayrshire
tabling member printed	Dr Philippa Whitford
uin	48382
answer	answer is ministerial correction date of answer 21/09/2022 answer text <p>NHS England has assessed that the use of clinical auscultation using a stethoscope is not a sensitive way of identifying the presence and clinical significance of heart valve disease or the detection of heart murmurs.</p><p>To support the early detection and diagnosis of heart valve disease NHS England has committed to launch at least 100 community diagnostic centres (CDCs) by 2024/25. These CDCs will provide services to detect heart murmurs, which are characteristic of heart valve and cardiovascular disease, through physiological measurement tests such as echocardiography and electrocardiograms, pathology tests, computerised tomography and magnetic resonance imaging scans.</p><p>In addition, the National Health Service is investing in cardiac networks to support whole pathway improvements. These networks have been developed to take an evidenced based, clinically led, whole pathway approach to improvement from prevention, diagnosis, treatment and end-of-life care.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 48381 question first answered 21/09/2022 11:18:08 answering member 4423 label Biography information for Will Quince
tabling member	4385 label Biography information for Dr Philippa Whitford

1504689

registered interest
date	05/09/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Silicosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he has plans to include silicosis as a notifiable disease under the Health Protection Regulations 2010.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	47530
answer	answer is ministerial correction date of answer 21/09/2022 answer text <p>The Health Protection (Notification) Regulations 2010 provide public health protection in England and place a statutory duty to notify the appropriate authority of certain infectious diseases and causative agents, such as COVID-19. This enables prompt investigation, risk assessment and response by specified bodies to cases of infectious disease or contamination that pose a significant risk to human health. <br>Silicosis is not an infectious disease or causative agent which presents or could present significant harm to human health. Therefore, it cannot be included under Schedule 1 or 2 of the regulations, as the powers are limited in accordance with the Public Health (Control of Diseases) Act 1984. Instead, it is associated with occupational exposure to respirable crystalline silica. The Health and Safety Executive recommend health surveillance should be considered for workers involved in high-risk occupations, such as construction and foundry work.</p> answering member constituency Sleaford and North Hykeham answering member printed Dr Caroline Johnson question first answered 21/09/2022 15:09:57 answering member 4592 label Biography information for Dr Caroline Johnson
tabling member	4131 label Biography information for Jim Shannon

1504776

registered interest
date	05/09/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Temporary Employment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the total cost to NHS hospitals was of using (a) agency and (b) bank staff in each region in England in the 2021-22 financial year.
tabling member constituency	Enfield North
tabling member printed	Feryal Clark
uin	47698
answer	answer is ministerial correction date of answer 20/09/2022 answer text <p>The information requested is not yet held in the format requested as the accounts for 2021/22 are currently being audited.</p> answering member constituency Newark answering member printed Robert Jenrick question first answered 20/09/2022 14:35:04 answering member 4320 label Biography information for Robert Jenrick previous answer version 17726 answering member constituency Suffolk Coastal answering member printed Dr Thérèse Coffey answering member 4098
tabling member	4822 label Biography information for Feryal Clark

1504891

registered interest
date	05/09/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Respiratory Syncytial Virus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, on what date he expects NHS England’s Palivizumab Expert Group to respond to the request from the JCVI to consider the eligibility of children with spinal muscular atrophy to receive the Palivizumab vaccination against respiratory syncytial virus.
tabling member constituency	St Albans
tabling member printed	Daisy Cooper
uin	47662
answer	answer is ministerial correction date of answer 20/09/2022 answer text <p>Respiratory syncytial virus (RSV) infection poses a serious risk for children with spinal muscular atrophy (SMA) with weakened respiratory muscles due to their condition. Following a letter from clinicians, the Joint Committee on Vaccination and Immunisation (JCVI) has requested that NHS England’s Palivizumab National Expert Group consider the eligibility of a sub-group of children with SMA to receive palivizumab vaccination this winter. This Group is preparing a briefing and on completion, it will meet and report the outcome of its discussion and recommendations to the JCVI. A specific date has yet to be confirmed.</p> answering member constituency Sleaford and North Hykeham answering member printed Dr Caroline Johnson grouped question UIN 47663 question first answered 20/09/2022 14:29:09 answering member 4592 label Biography information for Dr Caroline Johnson previous answer version 17723 answering member constituency Suffolk Coastal answering member printed Dr Thérèse Coffey answering member 4098
tabling member	4769 label Biography information for Daisy Cooper

1504892

registered interest
date	05/09/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Respiratory Syncytial Virus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to recommendations in the consensus statement of the 2017 International Conference on the Standards of Care on the use of Palivizumab for some categories of children with spinal muscular atrophy to protect from respiratory syncytial virus, if he will take steps to urgently review the eligibility criteria for the Palivizumab vaccine.
tabling member constituency	St Albans
tabling member printed	Daisy Cooper
uin	47663
answer	answer is ministerial correction date of answer 20/09/2022 answer text <p>Respiratory syncytial virus (RSV) infection poses a serious risk for children with spinal muscular atrophy (SMA) with weakened respiratory muscles due to their condition. Following a letter from clinicians, the Joint Committee on Vaccination and Immunisation (JCVI) has requested that NHS England’s Palivizumab National Expert Group consider the eligibility of a sub-group of children with SMA to receive palivizumab vaccination this winter. This Group is preparing a briefing and on completion, it will meet and report the outcome of its discussion and recommendations to the JCVI. A specific date has yet to be confirmed.</p> answering member constituency Sleaford and North Hykeham answering member printed Dr Caroline Johnson grouped question UIN 47662 question first answered 20/09/2022 14:29:09 answering member 4592 label Biography information for Dr Caroline Johnson previous answer version 17724 answering member constituency Suffolk Coastal answering member printed Dr Thérèse Coffey answering member 4098
tabling member	4769 label Biography information for Daisy Cooper

1504900

registered interest
date	05/09/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Care Workers: Allowances
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if his Department will offer support to local authorities to help social care providers to increase the mileage allowance paid to care workers.
tabling member constituency	Stockport
tabling member printed	Navendu Mishra
uin	47691
answer	answer is ministerial correction date of answer 20/09/2022 answer text <p>Under the Care Act 2014, local authorities have a duty to manage local care markets. The vast majority of care workers are employed by private sector providers which set their terms and conditions, including renumeration for travel costs, independently of Government. Local authorities work with care providers to determine fee rates, which should take account of employment costs, based on local market conditions.</p><p>We are committing £1.36 billion to the Market Sustainability and Fair Cost of Care Fund. The Fund will support local authorities to prepare markets for reform and move towards paying providers a fair cost of care. The Government continues to work with local government and care providers to understand the impact from challenges such as energy price rises and inflationary pressures.</p> answering member constituency Harborough answering member printed Neil O'Brien question first answered 20/09/2022 14:35:49 answering member 4679 label Biography information for Neil O'Brien previous answer version 17725 answering member constituency Suffolk Coastal answering member printed Dr Thérèse Coffey answering member 4098
tabling member	4811 label Biography information for Navendu Mishra

1504906

registered interest
date	05/09/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Sickle Cell Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans he has to (a) increase awareness of Sickle Cell disease and (b) improve the training for dealing with that disease among (i) nurses and doctors in training and (ii) practising NHS nurses and doctors.
tabling member constituency	East Ham
tabling member printed	Sir Stephen Timms
uin	47331
answer	answer is ministerial correction date of answer 20/09/2022 answer text <p>As part of this years’ World Sickle Cell Day, NHS England launched a new sickle cell disease awareness campaign on the signs and symptoms of sickle cell disease, aimed at urgent and emergency care staff and those living with the condition and their carers.</p><p>There have been recent improvements to the haematology medical curriculum, with understanding sickle cell disease and thalassemia now described in the curriculum as core competencies. Health Education England (HEE) provides e-learning which includes content on sickle cell disease. HEE has held discussions with the Royal Colleges of Pathology and Physicians to ensure this curriculum is deliverable to all four nations, in line with General Medical Council’s (GMC) standards. The Haemoglobinopathy Coordinating Centres also provide network development, leadership, learning and education.</p><p>The Sickle Cell Society and the All-Party Parliamentary Group on Sickle Cell and Thalassaemia report ‘No One’s Listening’ highlighted the lack of awareness of sickle cell disease among healthcare professionals. Officials are considering the report’s recommendations. NHS England estimates that awareness amongst accident and emergency medical and nursing staff, specifically of conditions such as sickle cell disease, is high across England and in areas where there is a higher prevalence of the condition. However, NHS England and other bodies continue with further awareness raising.</p><p>No specific assessment has been made regarding the extent of compliance to the National Institute for Health and Care Excellence’s (NICE) guidance on pain relief for sickle cell patients. The Care Quality Commission (CQC) considers evidence of how registered persons have met fundamental standards through its regulatory approach. The CQC will consider the processes providers have to ensure that best practice is implemented for quality standards, including NICE’s guidelines.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 47332 47333 question first answered 20/09/2022 14:27:53 answering member 4423 label Biography information for Will Quince previous answer version 17713 answering member constituency Suffolk Coastal answering member printed Dr Thérèse Coffey answering member 4098
tabling member	163 label Biography information for Sir Stephen Timms